DOP2013000206A - Inhibidores de la peptido desformilasa - Google Patents

Inhibidores de la peptido desformilasa

Info

Publication number
DOP2013000206A
DOP2013000206A DO2013000206A DO2013000206A DOP2013000206A DO P2013000206 A DOP2013000206 A DO P2013000206A DO 2013000206 A DO2013000206 A DO 2013000206A DO 2013000206 A DO2013000206 A DO 2013000206A DO P2013000206 A DOP2013000206 A DO P2013000206A
Authority
DO
Dominican Republic
Prior art keywords
desformilasa
peptide
inhibitors
compound
bacterial
Prior art date
Application number
DO2013000206A
Other languages
English (en)
Inventor
Donghui Qin
Andrew Nicholson Knox
Yuhong Fang
Andrew B Benowitz
Kelly M Aubart
James Hoffman
Joseph M Karpinski
Xiangmin Liao
Dongchuan Shi
Jared T Spletstoser
Original Assignee
Glaxosmithkline Ip No 2 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip No 2 Ltd filed Critical Glaxosmithkline Ip No 2 Ltd
Publication of DOP2013000206A publication Critical patent/DOP2013000206A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
    • C12Y305/01088—Peptide deformylase (3.5.1.88)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere a un compuesto de Fórmuia (I): a una sal farmacéuticamente aceptable del mismo, composiciones farmacéuticas correspondientes, preparación del compuesto y procedimientos la fabricación de un medicamento ûtiles en el tratamiento dìrigidos a infeccìones bacterianas e ìnhìbicìón de la actividad de la péptido desformilasa (PDF) bacteriana.
DO2013000206A 2011-03-09 2013-09-11 Inhibidores de la peptido desformilasa DOP2013000206A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161450784P 2011-03-09 2011-03-09

Publications (1)

Publication Number Publication Date
DOP2013000206A true DOP2013000206A (es) 2014-01-31

Family

ID=46798826

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2013000206A DOP2013000206A (es) 2011-03-09 2013-09-11 Inhibidores de la peptido desformilasa

Country Status (22)

Country Link
US (1) US8901119B2 (es)
EP (1) EP2684039A4 (es)
JP (1) JP2014516917A (es)
KR (1) KR20140011362A (es)
CN (1) CN103827665A (es)
AR (1) AR085698A1 (es)
AU (1) AU2012225365A1 (es)
BR (1) BR112013023057A2 (es)
CA (1) CA2829361A1 (es)
CL (1) CL2013002584A1 (es)
CO (1) CO6761343A2 (es)
CR (1) CR20130522A (es)
DO (1) DOP2013000206A (es)
EA (1) EA201391299A1 (es)
MA (1) MA35010B1 (es)
MX (1) MX2013010339A (es)
PE (1) PE20140439A1 (es)
SG (1) SG192948A1 (es)
TW (1) TW201249824A (es)
UY (1) UY33939A (es)
WO (1) WO2012122450A2 (es)
ZA (1) ZA201306415B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101383565B1 (ko) 2013-03-21 2014-04-09 박용희 고효율 해수 증발 장치 및 증발로프 모듈
GB201409536D0 (en) 2014-05-29 2014-07-16 Univ The Durham Chemically modifying peptides
CN109851614B (zh) * 2019-03-29 2023-01-13 中山大学 一类杂环类肽脱甲酰基酶抑制剂及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250700A (en) * 1991-05-01 1993-10-05 American Home Products Corporation Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents
US5399708A (en) 1993-11-12 1995-03-21 Eli Lilly And Company Pyrazolidin-3-one derivatives
UY27813A1 (es) 2002-05-31 2003-12-31 Smithkline Beecham Corp Inhibidores de la peptido-desformilasa
ATE361296T1 (de) 2003-04-03 2007-05-15 Merck Patent Gmbh Pyrazolidin-1,2-dicarbonsäure-1-((phenyl)-amid) 2-((phenyl)-amid) derivate als koagulationsfaktor xa inhibitoren zur behandlung von thrombosen
RU2007147959A (ru) 2005-06-08 2009-07-20 Новартис АГ (CH) Органические соединения
EP1994027A2 (en) * 2006-03-03 2008-11-26 Novartis AG N-formyl hydroxylamine compounds
UA108596C2 (xx) * 2007-11-09 2015-05-25 Інгібітори пептиддеформілази
CN101584694B (zh) * 2009-06-15 2011-01-12 华东师范大学 含2,5-二氢吡咯的肽脱甲酰基酶抑制剂及合成方法
IN2012DN00791A (es) 2009-06-29 2015-06-26 Genocea Biosciences Inc

Also Published As

Publication number Publication date
MX2013010339A (es) 2013-10-03
AR085698A1 (es) 2013-10-23
TW201249824A (en) 2012-12-16
WO2012122450A2 (en) 2012-09-13
AU2012225365A1 (en) 2013-09-12
CL2013002584A1 (es) 2014-02-21
SG192948A1 (en) 2013-09-30
CN103827665A (zh) 2014-05-28
CO6761343A2 (es) 2013-09-30
BR112013023057A2 (pt) 2016-08-02
EP2684039A2 (en) 2014-01-15
PE20140439A1 (es) 2014-05-04
MA35010B1 (fr) 2014-04-03
KR20140011362A (ko) 2014-01-28
US20130345120A1 (en) 2013-12-26
CA2829361A1 (en) 2012-09-13
CR20130522A (es) 2014-05-02
EA201391299A1 (ru) 2014-02-28
US8901119B2 (en) 2014-12-02
UY33939A (es) 2012-09-28
EP2684039A4 (en) 2015-03-11
WO2012122450A3 (en) 2014-04-03
AU2012225365A8 (en) 2013-09-19
JP2014516917A (ja) 2014-07-17
ZA201306415B (en) 2014-04-30

Similar Documents

Publication Publication Date Title
CO6382125A2 (es) Inhibidores de proteína quinasa
EA201490228A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
PH12015502002B1 (en) Tripeptide epoxy ketone protease inhibitors
MX345928B (es) Composiciones terapeuticamente activas y metodos de uso de las mismas.
EA201691803A1 (ru) Ингибиторы калликреина плазмы человека
EA201592250A1 (ru) Пиразолопирролидиновые производные и их применение в лечение заболеваний
EA026667B9 (ru) Фармацевтическая композиция для лечения вируса гепатита с
EA201791576A1 (ru) Ингибитор jak
CR20140086A (es) Tratamientos de combinación para hepatitis c
EA201491060A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
MY165087A (en) Neprilysin inhibitors
BR112012017402A2 (pt) inibidores de vírus de flaviviridae
UY32174A (es) Nuevos heterociclos sustituidos, composiciones farmaceuticas conteniendolos, procedimientos de preparacion y aplicaciones
EA201390917A1 (ru) Дигетероарильные соединения в качестве ингибиторов vps34
PH12016502103A1 (en) Novel disubstituted 1,2, 4-triazine compound
JO3326B1 (ar) مثبطات إيبوكسي كيتون بروتياز ثلاثي الببتيد
CR20120084A (es) Composiciones farmacéuticas para el tratamiento del cáncer y otras enfermedades o trastornos
UA111599C2 (uk) Композиція каспофунгіну
MX2012013879A (es) Derivados de hidroxipiridona, composiciones farmceuticas de los mismos y su uso terapeutico para tratar enfermedades proliferativas.
MX2014003701A (es) Compuestos para el tratamiento y profilaxis de enfermedad por el virus sincitial respiratorio.
BR112014001425A2 (pt) forma de dosagem farmacêutica, composição farmacêutica, e, composto (i) ou sal farmaceuticamente aceitável do mesmo
EA201490573A1 (ru) Соединение бензотиазолона
DOP2013000206A (es) Inhibidores de la peptido desformilasa
CO6460763A2 (es) Métodos y formulaciones ectoparasiticidas
AR083322A1 (es) Compuesto (3-{[{4-[4-amino-2-(etoximetil)-1h-imidazol[4,5-c]quinolin-1-il]butil}(n,n-dietilglicil)amino]metil}fenil)acetato de metilo